A/Prof Catriona McNeil is a Medical Oncologist based at Chris O`Brien Lifehouse and Royal Prince Alfred Hospital (RPAH), whose primary interests are management of breast cancer, and phase 1 studies. She has driven the introduction of cancer immunotherapies (anti-CTLA4 and anti-PD1) to her institution, with flow-on effects for other tumour streams. She is the key departmental educator in the use of these new cancer therapies. She has been a co-author on numerous immunotherapy-related manuscripts and more recently has authored several manuscripts related to communication and ethical issues in the era of modern cancer therapy.
Abstracts this author is presenting: